The morphogenesis of the vertebrate hindbrain involves a transient segmentation process leading to the formation of reiterated organisation units called rhombomeres (r). A number of regulatory genes expressed with a rhombomere-specific pattern have been identified, including the gene encoding the transcription factor Krox-20, which is restricted to r3 and r5. We have previously demonstrated that in r3 and r5 Krox-20 directly controls the transcription of Hoxa-2 and Hoxb-2. In the present study, we provide evidence that Krox-20 is required for the expression of another Hox gene, Hoxb-3, in r5 specifically. Furthermore, the regulatory role of Krox-20 is not restricted to the control of Hox gene expression, since it is also involved in the activation of a receptor tyrosine kinase gene, Sek-1, in r3 and r5 and in the repression of thefollistatin gene in r3 but not in r5. In conclusion, at least five regulatory genes belonging to different families are under the direct or indirect control of Krox-20 in r3 and/or r5 and this transcription factor therefore appears as a key regulator of gene expression in the developing hindbrain. © 1997 Elsevier Science Ireland Ltd.
Introduction
Hindbrain regionalization and morphogenesis involves a segmentation process highly conserved during vertebrate evolution (Lumsden, 1990; Wilkinson, 1993; Keynes and Krumlauf, 1994) . In this region of the neural tube, a series of 7-8 periodic swellings, called rhombomeres, are observed transiently along the anterior-posterior axis. Investigation of their properties and functions during the last few years has indicated that the rhombomeres play an essential function in establishing the developmental pattern governing hindbrain and cranio-facial morphogenesis. In particular, they constitute metameric units for neurogenesis and neuronal organisation (Lumsden and Keynes, 1989; Marshall et al., 1992; Carpenter et al., 1993; Clarke and Lumsden, 1993) . The genes encoding proteins involved in intercellular signalling like growth factors (Wilkinson, 1990 ) and receptor-type tyrosine kinases Becker et al., 1994; Ruiz and Robertson, 1994; Ellis et al., 1995) . An important issue in the study of the molecular mechanisms controlling hindbrain segmentation is now to understand the precise function of these genes and to determine the regulatory links possibly existing between them.
Krox-20 encodes a transcription factor with a DNA-binding domain consisting of three C2H=-type zinc fingers (Chavrier et al., 1988 (Chavrier et al., , 1990 Vesque and Charnay, 1992) . In the hindbraln, it is expressed before morphological segmentation in two non-adjacent stripes which prefigure, and then coincide with, rhombomeres 3 and 5 (Wilkinson et al., 1989a) . Krox-20 inactivation leads to a profound perturbation of hindbrain morphogenesis: although presumptive territories of rhombomeres 3 and 5 form normally at early stages of hindbrain development, these two rhombomeres are not maintained later on and derived structures are eliminated (Schneider-Maunoury et al., 1993 , 1997 Swiatek and Gridley, 1993; Jacquin et al., 1996) . Since Krox-20 is a transcription factor, its function within the hindbrain is likely to involve the direct activation or repression of downstream genes. We have shown previously that two Hox genes expressed in r3 and r5, Hoxa-2 and Hoxb-2, are indeed direct transcriptional targets of Krox-20 within these rhombomeres Nonchev et al., 1996a; Vesque et al., 1996) .
In the present work, to investigate whether other genes might be involved in mediating the Krox-20 hindbrain phenotype, we have searched for additional genes lying downstream of Krox-20 in the regulatory cascade, by analysing possible modifications of their expression pattern in Krox-20 -/-embryos. In a first step, we have investigated whether another Hox gene, Hoxb-3, which is expressed at a high relative level in r5 (Wilkinson et al., 1989b; Hunt et al., 1991) , is affected by the Krox-20 mutation. Indeed, we have found that up-regulation in r5 is eliminated. Another interesting category of possible targets is the Eph family of tyrosine kinase genes which encode transmembrane receptors for a corresponding family of membrane-bound ligands (reviewed in Brambilla and Klein, 1995) . Several of these genes are expressed in a rhombomere-specific manner and at least four of them overlap with the Krox-20 expression pattern Nieto et al., 1992; Becker et al., 1994; Ganju et al., 1994; Henkemeyer et al., 1994; Ruiz and Robertson, 1994) . These genes are thought to play an important role in axonal guidance at later stages of development (Cheng et al., 1995; Drescher et al., 1995; Henkemeyer et al., 1996) , but one of them, Sek-1, has been recently implicated in the establishment of segmental territories within the hindbrain , (Xu et al., 1995) . Sek-1 is expressed at a high relative' level in r3 and r5 (GilardiHebenstreit et al., 1992; Nieto et al., 1992) and we show here that this expression is dependent on the activity of the Krox-20 gene. Finally, we have examined the effect of the Krox-20 mutation on several other genes with regionalised expression within the hindbrain, overlapping or not with Krox-20. We have found that they were not affected, with the exception of thefollistatin gene which encodes a factor able to bind and inhibit activin (Shimasaki et al., 1988) and is normally restricted to even-numbered rhombomeres within the hindbrain (Albano et al., 1994; Feijen et al., 1994) . In Krox-20 -/-embryos the follistatin gene was expressed in r3, indicating that in this case Krox-20 is involved, directly or indirectly, in the repression of gene expression.
Results
To identify genes downstream of Krox-20 in the regulatory cascade controlling hindbrain segmentation, we selected candidates that had overlapping patterns of expression and investigated whether the Krox-20 mutation affected these patterns. Although, as indicated above, Krox-20 inactivation leads to the disappearance of r3 and r5, there is a time window during which r3 and r5 prospective territories are present in Krox-20 -/-embryos (up to the 12-14-somite (12-14s) stage for r3 and up to 10 dpc for r5; Schneider-Maunoury et al., 1993 , 1997 . We have therefore confined our studies to this period and examined the time course of expression of the candidate genes in great detail, using whole mount in situ hybridisation. In addition, we took advantage of the insertion of the lacZ coding sequence within the mutant Krox-20 allele, resulting in the synthesis of a hybrid Krox-20/lacZ protein which has lost Krox-20 activity but retained /3-galactosidase activity (SchneiderMaunoury et al., 1993) . The expression of the chimeric gene has been shown to faithfully recapitulate Krox-20 expression pattern, both in heterozygous and homozygous mutants (Schneider-Maunoury et al., 1993; Topilko et al., 1994; Levi et al., 1996) . We have therefore used X-gal staining to ascertain the presence of prospective r3 and r5 in double detection experiments. In addition, /~-galactosidase activity was useful as a positional marker since the major part of these studies was performed before segmental units could be morphologically identified. X-gal staining was kept minimal in order to avoid quenching of the hybridisation signal. Therefore, it did not reflect the complete extent of r3 and r5 prospective territories.
Sek-1 up-regulation in prospective r3 and r5 correlates with Krox-20 expression
Sek-1 has been shown previously to be expressed at high relative level in r3 and r5 in the developing hindbrain Nieto et al., 1992; Irving et al., 1996) . As a first step to investigate a possible regulatory link with Krox-20, we performed a detailed compar-ison of their expression patterns in control embryos. At 7.75 dpc (0-somite), a large domain of homogeneous Sek-1 expression appeared in the hindbrain, covering the region between the pre-and post-otic sulci (data not shown). This pattern persisted up to the 2-3s stage, and progressively, by the 3-4s stage the expression was up-regulated in the anterior part of this area (Fig. 1A) . Double detection with X-gal in heterozygous mutant embryos demonstrated that the domain of Sek-1 high expression precisely coincided with the narrow band of cells initially activating (Fig.  1B) . A few hours later, at the 4-6-somite stage, high level Sek-1 expression was restricted along the antero-posterior axis to prospective r3 and to a more posterior domain consisting of only a few cells mainly in the lateral neural plate at the level of post-otic sulcus and corresponding to prospective r5 as shown by X-gal staining (Fig. 1D,E) . Lower Sek-1 expression was observed in prospective r2, r4 and r6. Subsequently, at the 6-8s stage, both stripes of high level Sek-1 expression broadened and formed sharp boundaries (Fig.  1G ), precisely coinciding with Krox-20 expression in r3 and r5 (Fig. 1H) . Expression was down-regulated in r4, but persisted at low level in r2 and in the dorsal part of r6. At this stage, Sek-1 RNA was also observed in the lateral mesoderm adjacent to rhombomeres 3-6 (Fig. 1G ). In conclusion, these data indicate a constant overlap during this period between the Sek-1 high expression domains and the Krox-20-positive territories within the hindbrain.
Krox-20 inactivation prevents Sek-1 up-regulation in r3 and r5
In homozygous mutant embryos, the initial activation of Sek-1 at low level in a broad domain occurred normally (Fig. 1C) . However, Sek-1 up-regulation in prospective r3 and r5 did not happen, while normal activation of Krox-20/ lacZ was observed (Fig. IF,I -K). At the 6-8s stage, when Sek-1 was strongly expressed in r3 and r5 in control embryos, no such domains were observed at the level of the X-gal stained territories in J) . Nevertheless low levels of Sek-1 RNA were detected in r2 to r6 and Sek-1 expression in the lateral head mesoderm appeared comparable to that of control embryos. Absence of up-regulation of Sek-1 in r5 persisted in homozygous mutant embryos at later stages of development (10-14s), while the domain of expression of Krox-20-LacZ corresponding to r5 was still equivalent in size and intensity to that of heterozygous embryos (Fig. 1K-M and data not shown). In conclusion, our data indicate that Krox-20 inactivation prevents Sek-1 up-regulation in prospective rhombomeres 3 and 5.
Sek-1 expression in the neural crest is also affected by the Krox-20 mutation
Around 9.5 dpc Krox-20 and Sek-1 are expressed in populations of neural crest cells emerging from the r5/r6 boundary region and migrating caudally to the otic vesicle into the third branchial arch ( Fig. 2A-C) (Wilkinson et al., 1989a; Nieto et al., 1992; Schneider-Maunoury et al., 1993) . Although it was not determined previously whether the same cells expressed the two genes, we have also analysed this aspect of Sek-1 expression in Krox-20 -¢-embryos. As noticed earlier (Schneider-Maunoury et al., 1993 ) the pattern of Krox-20/lacZ expression in neural crest cells was different in heterozygous and homozygous mutant embryos at 9.5 dpc: while X-gal staining was restricted to post-otic migrating cells in heterozygous embryos, Krox-20/lacZpositive cells were observed both rostral and caudal to the otic vesicle in the homozygous mutant (Fig. 2D) . No Sek-1 transcripts were detected in these populations of neural crest migrating presumably from r5 in Krox-20 -/-embryos ( Fig.  2E,F ). In conclusion, these data suggest that the Sek-l-positive neural crest cells in control embryos also express Krox-20 and that the disruption of the latter gene prevents Sek-1 activation in these crest cells.
At the 10-14s stage, Sek-1 expression is not restricted to the hindbrain and neural crest cells. Additional Sek-l-positive territories include diencephalic and telencephalic areas, mesenchymal cells lateral to the hindbrain, the otic vesicle, condensing somites and the non-segmented lateral mesoderm in the posterior part of the embryo (Fig. 2B ,C and data not shown) . These territories do not express Krox-20 and we found accordingly that Sek-1 expression was not affected there by Krox-20 inactivation (Fig. 2E ,F and data not shown).
Krox-20 is required for Hoxb-3 up-regulation in r5
At early stages of hindbrain development, the rostral limit of Hoxb-3 expression within the neural tube has been reported to coincide with the r4/r5 rhombomere boundary (Wilkinson et al., 1989b; Hunt et al., 1991; Sham et al., 1992) . Our analysis of Hoxb-3 expression in control embryos between 8.5 and 9.5 dpc confirmed previous work (Fig. 3A ,D and data not shown). In addition it revealed that Hoxb-3 expression was not uniform along the rostrocaudal axis, with a much stronger signal in r5 (Fig. 3A,D) . Expression was also higher in the prospective posterior spinal cord, where the tube was not yet closed. In homozygous mutant embryos of the same developmental stages, high relative level expression of Hoxb-3 in the anterior domain was not observed (Fig. 3B,E) , although r5 cells were still present (see Fig. 1I and 2D). However, lower level expression persisted in the posterior hindbrain. To determine whether this low level Hoxb-3 expression domain included prospective r5, we performed double in situ hybridisation with a Hoxb-1 probe, which provided a marker for prospective r4 (Wilkinson et al., 1989b; SchneiderMaunoury et al., 1993) . This revealed that a low level of Hoxb-3 expression was maintained in prospective r5, since no gap was observed between the Hoxb-1-and Hoxb-3-positive domains (Fig. 3C,F ). In conclusion, our data indi-cate that inactivation prevents up-regulation of Hoxb-3 in rhombomere 5 but allows the maintenance of a low level of expression similar to that in more posterior regions.
CRABP-I is another gene expressed in r5, in addition to r4 and r6, in 9 dpc embryos. At this stage, prospective r5 is still present in homozygous mutant embryos and CRABP-I expression is maintained in this territory (data 
Krox-20 negatively regulates follistatin expression in r3
It has been shown that interactions between adjacent rhombomeres are important for the control of gene expression within the hindbrain and for neural crest generation (Graham et al., 1994; Graham and Lumsden, 1996) . Furthermore, we have demonstrated recently that the Krox-20 mutation affects neural development and architecture in r2 and r6 (Schneider-Maunoury et al., 1997) . This raised the possibility of an effect of Krox-20 inactivation on gene expression in even-numbered rhombomeres. We have therefore analysed its consequences on the expression pattern of three genes restricted to even-numbered rhombomeres: Sek-2, Hoxb-1 and follistatin.
In the hindbrain, Sek-2 is exclusively expressed in prospective r4 in 0-4s embryos ( Fig. 4A) (Becker et al., 1994; Ganju et al., 1994; Ruiz and Robertson, 1994) . This expression pattern was not affected by the Krox-20 mutation (Fig.  4B) . Hoxb-1 expression, from the 4-6s stage, is also restricted to prospective r4 and persists within this rhombomere beyond 10.5 dpc (Fig. 4C) (Murphy et al., 1989; Wilkinson et al., 1989b) . As reported previously, we found no modification of its expression pattern in homozygous mutant embryos up to 9 dpc (Schneider-Maunoury et al., 1993 and data not shown). However, from 9.5 dpc, although the level of expression of Hoxb-1 appeared normal, the domain of expression was reduced (Fig. 4D and data not shown): at 10.5 dpc, in the ventral region the width of the Hoxb-l-positive territory was about 80% that of the control and the effect was even more pronounced in the dorsal part of the neural tube (Fig. 4D) . We have shown recently that this late modification of the Hoxb-1 expression pattern actually reflects a reduction in size of rhombomere 4 itself (Schneider-Maunoury et al., 1997) .
In the mouse hindbrainfollistatin is first expressed in two prominent stripes corresponding to prospective r2 and r4 and at around 9.5 dpc it is also progressively activated in r6 (Albano et al., 1994) . In agreement with these observations, double detection for follistatin transcripts and /3-galactosidase activity in 7-8s heterozygous embryos demonstrated its expression in prospective r2 and r4 only (Fig. 4E) . However, analysis of Krox-20 homozygous mutants of the same stage revealed a large continuous domain offollistatin expression, whose posterior limit coincided with the r4/r5 boundary (Fig. 4F ). These data were confirmed by analysis of follistatin expression at the 6s stage, when the extension of prospective r3 is maximal in Krox-20 -/-embryos ( Fig. 4G-I ). Although lacZ expression is slightly mosaic in the r3 territory (Fig. 4I ), follistatin appears expressed in all cells within the r2-r3-r4 domain (Fig. 4H) . Therefore, the follistatin-positive domain in Krox-20 -/-embryos includes the prospective r3 cells, but not the prospective r5 territory. At the 12s stage, when r3 has almost disappeared in Krox-20 -/-embryos, follistatin was maintained in r2 and r4, r5 remained negative and a low signal appeared in r6 (data not shown). These data suggest that Krox-20 inactivation results in a specific activation of follistatin expression in r3 but does not Fig. 1 . Krox-20 is required for Sek-1 up-regulation in r3 and r5. Wild type mouse embryos (A,D,G,L) and one homozygous embryo (M) were analysed by whole mount in situ hybridisation with the Sek-1 probe. Krox-20 heterozygous (B,E,H) and homozygous (C,F,I-K) mutant embryos were subjected to double detection to reveal both Sek-1 mRNA by whole mount in situ hybridisation (purple blue) and/3-galactosidase activity by X-gal staining (turquoise blue). (A~2) Two-to 4-somite embryos showing the appearance of a large Sek-1 expression domain. The rostral reinforcement observed in the wild type (A) and in the heterozygous embryo, where it overlaps with prospective r3 labelled by X-gal (B), is not seen in the homozygous mutant embryo (C). (D-F) Four-to 6-s embryos. High level Sek-1 expression is confined to presumptive r3 and a few r5 ceils in the dorsal neural plate in the wild type embryo (D) and in the heterozygous mutant embryo (E) where it co-localises with X-gal staining. Such high level expression domains are not observed in the homozygous mutant embryo despite the presence of r3 and r5 (F). (G-J) Six-to 8-s embryos. In wild type (G) and heterozygous (H) embryos, strong Sek-1 expression is observed in two broad transverse stripes, extending across the neuroepithelium up to, but not into the floor plate and corresponding to r3 and r5 (arrowheads); the otic placode, lateral mesenchyme and, at a lower level, r2 are also Sek-l-positive (arrows), although these territories do not express Krox-20/lacZ. Transversal stripes of strong Sek-I expression are not detected in the homozygous mutant embryo (I), while the presence of the turquoise blue X-gal precipitate indicates the persistence of r3 and r5 cells. In another homozygous mutant embryo (J), the presence of prospective r3 (arrow) was more clearly established by longer staining with X-gal. No Sek-1 expression is detected at this level. A few dispersed cells expressing Sek-1 at low level were occasionally observed posterior and ventral to the otic vesicle. It was not possible to detennine whether such cells were also present in control embryos. In (E) a limited/3-galactosidase detection was also performed, allowing X-gal staining of r5 but not of crest cells.
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The Krox-20 mutation does not affect the regulation of the dorsally expressed genes Msx-1 and Wnt-1
To investigate whether Krox-20 inactivation might affect dorso-ventral patterning, we analysed the expression patterns of the Msx-1 and Wnt-1 genes. At the level of the hindbrain, Msx-1 and Wnt-1 are expressed only along the dorsal midiine of the neuroepithelium in 9.5 dpc embryos (Wilkinson et al., 1987; Robert et al., 1989) . Double staining with X-gal of Krox-20 heterozygous mutant embryos showed that their domains of expression overlapped with the X-gal stripes in r3 and r5 (Fig. 5A,C) . No modification of these patterns was observed in Krox-20 -/-embryos, neither in the rhombomeres directly affected by the mutation nor in even-numbered rhombomeres (Fig. 5B,D) .
Discussion

Krox-20 is an essential regulator of gene expression in r3 and r5
This report, in combination with previous studies (Schneider-Maunoury et al., 1993; Nonchev et al., 1996a) , demonstrates that the inactivation of Krox-20 leads to profound modifications of the pattern of gene expression in prospective r3 and r5 which are schematically summarised in Fig. 6 . The mutation affects a variety of putative regulatory genes belonging to different families, establishing Krox-20 as a central regulator of gene expression in these rhombomeres. So far we have demonstrated that Krox-20 controls the expression of three Hox genes, of one member of the Eph family of receptor tyrosine kinase genes and of the follistatin gene. Since Krox-20 is a sequence-specific transcriptioq factor (Chavrier et al., 1990; Nardelli et al., 1991) , an important issue is whether it modulates the transcription of these genes directly, binding to cis-acting regulatory elements located in their vicinity. We have shown that this is the case for at least three of these genes. DNA fragments carrying r3/r5-specific transcriptional enhancers have been identified upstream of the mouse Hoxa-2 and Hoxb-2 genes Nonchev et al., 1996a) . These elements contain Krox-20 binding sites which are required for enhancer activity. Furthermore, ectopic expression of Krox-20 activates transcription of a reporter gene placed under the control of these enhancers. These elements are therefore likely to be responsible for mediating the direct transcriptional up-regulation of Hoxa-2 and Hoxb-2 by Krox-20 in r3 and r5. We have also identified similar elements upstream of the orthologs of Hoxa-2 and Hoxb-2 in several vertebrate species (Nonchev et al., 1996b; Vesque et al., 1996) , suggesting that the involvement of Krox-20 in the regulation of Hox genes was a characteristic of early vertebrates which was conserved during evolution. More recently we have identified a r3/r5 enhancer upstream of the Sek-1 gene (Theil et al., unpublished data). It contains Krox-20 binding sites and preliminary analysis suggests that these are essential for its activity. Therefore, the molecular basis of the regulation of Hoxa-2 and Hoxb-2 and of Sek-1 appears similar in these rhombomeres. It remains to be determined whether Hoxb-3 and follistatin expression in r5 and r3, respectively, requires a direct interaction of Krox-20 with cis-acting elements in the vicinity of these genes.
Negative control of follistatin gene expression
In the case of the follistatin gene, the effect observed on transcription in r3 is a Krox-20-dependent repression. So far, Krox-20 has only been shown to act as a positive transcriptional activator (Chavrier et al., 1990; Vesque and Charnay, 1992; Sham et al., 1993; Nonchev et al., 1996a) . If the repression offollistatin transcription occurs in a direct manner, this would mean that Krox-20 can act both as a positive and a negative transcriptional regulator within the same cells. This differential activity may require the interaction of Krox-20 with distinct co-factors. In any case, our observation of the involvement of Krox-20 in follistatin repression in r3 only is consistent with recent grafting heterozygous (C) and homozygous (D) mutant embryos double stained with the r4-specific Hoxb-1 probe and with X-gal which reveals a low level of 13-galactosidase activity remaining in r5 in the heterozygous embryo. The spotted /3-galactosidase labelling observed in even-numbered rhombomeres corresponds to remnants of the exit points of cranial nerves . Note the reduction in size of r4, especially of its dorsal part in the . (E,F) Whole mount 7-8s Krox-20 heterozygous (E) and homozygous (F) mutant embryos double stained forfollistatin mRNA and/~-galactosidase activity; (E) Follistatin RNA is observed in r2 and r4 in the hindbrain, while X-gal staining labels r3 and r5. 
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experiments performed in chick embryos. They have shown that when r3, but not r5, is transplanted in the position of r4, Krox-20 expression is down-regulated and follistatin expression is activated in the grafted tissue (Graham and Lumsden, 1996) .
Complexity of rhombomere-specific transcriptional ,,, regulation
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We have shown recently that the activity of the Hoxb-2 enhancer necessitates the integrity of another DNA sequence in addition to the Krox-20 binding sites (Vesque et al., 1996) . This suggests that Krox-20 requires the binding of a co-operating factor to this site in order to activate transcription in r3 and r5. The present data are also consistent with the involvement of additional factors in gene control by while Krox-20 is expressed both in r3 and r5, it controls Hoxb-3 andfollistatin transcription in one rhombomere only, r5 in the case of Hoxb-3 and r3 in the case of follistatin. If these regulations are direct, this suggests the implication of co-operating factors whose activities are restricted along the antero-posterior axis. Otherwise, it may be that transcription factors downstream to Krox-20 in the regulatory cascade have their activities regulated differentially in r3 and r5. It should also be noted that Krox-20 is not responsible for all the aspects of the expression of its target genes in r3 and r5. Despite the inactivation of Krox-20, the early activation of Sek-1 in a domain which includes prospective r3 occurs normally. At later stages, low levels of Sek-1 and Hoxb-3 expression are maintained in the affected rhombomeres. Similar observations have been made in Krox-20 homozygous mutant embryos concerning the expression of the Hoxb-2 and Hoxa-2 genes in r5 (Schneider-Maunoury et al., 1993; Nonchev et al., 1996a) . These data suggest that the transcription of these genes in r3 and/or r5 results from the combination of a low level, Krox-20-independent expression and a high level expression controlled by Krox-20. These two activation modes are likely to be dependent on distinct cis-acting elements as well Nonchev et al., 1996a) . Within a single rhombomere the regulation of the expression of a specific gene therefore appears as a complex process involving multiple, at least partially independent, genetic pathways.
Regukztion and function of Sek-1 in neural crest cells
Krox-20 and Sek-1 are both expressed in a population of neural crest cells emerging from the r5/r6 boundary region and migrating into the third branchial arch. The fact that Krox-20 inactivation eliminates Sek-1 expression in these cells, while Krox-20/lacZexpression is maintained, suggests that the two genes are co-expressed in the same crest cells and that, like in r3 and r5, Sek-1 is downstream to Krox-20 in the regulatory cascade. In Krox-20 -/-embryos, the Krox-20/ lacZ-positive crest cells have an abnormal migratory pattern: instead of emerging only from the r5/r6 boundary region and migrating caudally to the otic vesicle toward the third branchial arch, they emerge rostrally and caudally to prospective r5 and migrate on both sides of the otic vesicle (Fig. 2) (Schneider-Maunoury et al., 1993) . Although this behaviour might be related to general topological modifications within the hindbrain-branchial region, they may also originate from a defect in the neural crest cells. It has been shown that members of the Eph family of tyrosine kinase receptors are involved in axonal guidance (Cheng et al., 1995; Drescher et al., 1995; Henkemeyer et al., 1996) . There might be similarities between the cellular interactions involved in the guidance of growth cones and those controlling the migration of neural crest cells. Indeed, recent experiments involving expression of a Sek-1 dominant negative mutant in Xenopus embryos resulted in the disruption of the targeted migration of third arch neural crest, implicating the Eph family in crest pathfinding (Smith et al., submitted for publication). Therefore, an attractive possibility is that it is the absence of Sek-I which is the direct cause of the abnormal navigation of Krox-20/lacZ-positive crest cells in Krox-20 -/-embryos.
Function of the Krox-20 gene during hindbrain segmentation
As indicated above, the inactivation of Krox-20 leads to a progressive and complete elimination of r3 and r5. An important question concerns the precise mechanisms affected by the mutation at the cellular level and the identity of the genes relaying Krox-20 action. Several non-exclusive hypotheses can be envisaged for the generation of the phenotype and we will discuss the possible involvement of the known Krox-20 target genes. These hypotheses can be grouped in two classes. In the first one, the disappearance of the rhombomere is not directly linked to a modification of its identity, i.e. the downstream genes involved do not determine characters which distinguish rhombomeres from one another in relation to their rostro-caudal position. Two major possibilities can be envisaged. (i) Krox-20 might be required after a certain stage of rhombomere development or of cell differentiation to prevent programmed cell death. However, such an hypothesis is not supported by a preliminary analysis which failed to detect massive apoptosis in the territories of prospective r3 and r5 in homozygous mutant embryos (Voiculescu et al., unpublished result) .
(ii) Krox-20 might be necessary for continued cell proliferation within r3 and r5. This idea is consistent with the fact that Krox-20 constitutes an immediate-early serum response gene in cultured cells (Chavrier et al., 1988) . However, such a role of Krox-20 is not sufficient to explain all observations: for instance, at 9 dpc the r5 territory, as defined by Xgal staining, has almost a normal extent, while at 10.5 dpc the rhombomere has completely disappeared. Simple cessation of cell proliferation in r5 would be expected to leave a detectable remnant at 10.5 dpc. Similarly, the early extinction of Krox-20/lacZ expression in the mutant is not consistent with this sole hypothesis.
The second class of hypotheses postulates a link between r3/r5 disappearance and a change in rhombomeric identity. This possibility is attractive in view of the dramatic modifications of Hox gene expression observed in the mutant and of the expected role of Hox genes in the specification of the rostro-caudal identity of the rhombomeres (Wilkinson et al., 1989b; Zhang et al., 1994) . In this respect, Krox-20 might be required to prevent prospective r3 and r5 cells from adopting an even-numbered rhombomere phenotype and in consequence to mix with cells from adjacent rhombomeres. If we consider the Hox genes downstream to Krox-20 identified so far, only one even-numbered rhombomere, r2, has a 'code' similar to that of the r3/r5 prospective territories in the homozygous mutant embryos (i.e. low level or no expression for all three markers). A related hypothesis postulates that what might be important for generating the phenotype is only an aspect of rhombomere identity determined by Krox-20 and required for preventing mixing with cells from even-numbered rhombomeres. This might not involve Hox genes. In agreement with such an idea is the observation of the implication of Krox-20 in the up-regulation of Sek-1 which may be involved in the segregation between odd-and even-numbered rhombomere cells (Xu et al., 1995) . Finally, it may be that Krox-20 inactivation leads to an aberrant cellular identity in prospective r3 or r5 which is recognised by the cellular machinery and leads indirectly to cell death or growth arrest, bringing us back to the first two hypotheses.
In conclusion, the available data do not allow to discriminate between the different hypotheses on the precise role of Krox-20. The analysis of the phenotypes associated with the inactivation of Sek-1 or with the combination of the Hoxa-2 and Hoxb-2 mutations, as well as lineage tracing experiments in Krox-20 homozygous mutant embryos, should provide clues to unravel this important question.
Experimental procedures
Embryo genotyping and X-gal staining
Mouse embryos produced from crosses between males and females heterozygous for the Krox-20-LacZ fusion mutation were collected at the appropriate developmental stages, varying from 8.0 and 10.5 dpc, considering the day of the plug as day 0.5 of development. They were removed from the uterus in fresh PBS, separated from the yolk sac and rapidly fixed by immersion in cold 4% paraformaldehyde (PFA) in PBS. During the course of these experiments and other studies (Schneider-Maunoury et al., 1993 , 1997 , we never noticed any difference between wild type and heterozygous mutant embryos, except for lacZ expression. Therefore, we will refer to both types of embryos as controis. Embryo genotyping was performed by PCR, using yolk sac DNA, as previously described (SchneiderMaunoury et al., 1993) . For detection of/3-galactosidase activity only, embryos were fixed for 15 min in 4% PFA in PBS at room temperature, then washed three times in PBS and incubated in X-gal staining buffer overnight at 30°C as described . For double detection by in situ hybridisation and X-gal staining, embryos were fixed in 4% PFA for 10 min in ice, washed with cold PBS and then stained in X-gal for 2-4 h at 37°C. Staining was monitored by microscope observation to stop the reaction as soon as an adequate labelling was achieved. Limited X-gal staining was essential to minimise quenching of the in situ hybridisation signal, in cases of overlap. The embryos were then refixed and processed for in situ hybridisation as described below.
RNA probes for in situ hybridisation
RNA probes suitable for in situ hybridisation were generated by transcription of the following mouse gene DNA fragments. Sek-l: a 1.2 kb cDNA fragment corresponding to positions 652-1834 ; Sek-2: a 1.3 kb cDNA fragment corresponding to positions 1763-3040 (Becker et al., 1994) ; Hoxb-l: a 0.8 kb genomic EcoRI fragment (Wilkinson et al., 1989b) ; Hoxb-3: a 0.7 kb genomic BamHI-HindIII fragment (Wilkinson et al., 1989b) ; Msx-l: an SphI genomic fragment (Robert et al., 1989) ; CRABP-I: a 0.76 kb EcoRI genomic fragment (Stoner and Gudas, 1989) ; Wnt-l: a 1.8 kb XbaI genomic fragment (Fung et al., 1985) ; follistatin: a HincII-BamHI genomic fragment (Albano et al., 1994) . All fragments were cloned in plasmids containing T7, SP6 or T3 RNA polymerase promoters and these were linearised with the appropriate restriction enzyme before in vitro transcription. Synthesis of the probes was performed in the presence of a mixture of 0.5 mM GTP, 0.5 mM ATP, 0.5 mM CTP, 0.33 mM UTP and 0.17 mM digoxigenin-UTP (Boehringer Mannheim). The probes were precipitated in cold ethanol containing 95 mM LiC1 and the amount and the size of the RNA were checked by gel electrophoresis. The probes were used directly for hybridisation, without partial hydrolysis.
Whole mount in situ hybridisation
Whole mount in situ hybridisation was performed as described previously (Wilkinson, 1992) , with minor modifications. Briefly, the embryos were fixed overnight in 4% PFA in PBS at 4°C, dehydrated in methanol/PBT (PBT: PBS with 0.1% Tween 20) and stored in 100% methanol at-20°C until use. They were then rehydrated in descending methanol/PBT solutions, bleached 30 min in 2% hydrogen peroxide in PBT, treated with 10 /zg/ml of proteinase K (Boehringer) in PBT for 15 min at room temperature, washed in 2 mg/ml glycine in PBT and post-fixed in 0.2% glutaraldehyde/4% PFA in PBT for 30 min and thoroughly washed with PBT before hyhridisation. The neural tubes of 10.5 dpe embryos were dissected in PBT just before bleaching and they were subsequently treated as described above. Embryos were pre-hybridised at 70°C for 1 h in 50% formamide, 5x SSC (pH 7.4), 1% SDS, 50 /~g/ml heparin (Sigma, H3125) and 50 /~g/ml yeast RNA. For hybridisation, this mix was replaced, approximately 2/~g/ml digox-igenin-labelled RNA probe were added and the incubation was performed overnight at 70°C. In double detection experiments, the two probes were added together.
Post-hybridisation washes were as follows: twice at 70°C with 50% formamide, 5x SSC (pH 7.5) and 1% SDS, three times at room temperature with solution A (500 mM NaC1, 10 mM Tris-HC1, pH 7.5 and 0.1% Tween 20), twice with 100 gg/ml RNase A in solution A at 37°C and finally twice at 65°C in 50% formamide, 2× SSC (pH 7.5). Embryos were then transferred in TBST (140 mM NaCI, 27 mM KC1, 25 mM Tris-HC1 pH 7.5, 0.1% Tween 20, 2 mM levamisole) and pre-blocked in 10% decomplemented goat serum for 2 h with agitation. They were then incubated overnight at 4°C with rocking in the anti-digoxygenin antibody conjugated with alkaline phosphatase (Boehringer Mannheim) diluted 1:2000 in TBST containing 1% goat serum. Alkaline phosphatase activity was revealed in NTMT (100 mM NaC1, 100 mM Tris-HC1 pH 9.5, 50 mM MgC12, 0.1% Tween 20, 2 mM levamisole) by addition of BCIP/ NBT (5-bromo-4-chloro-3-indolyl-phosphate/nitro-bluetetrazolium chloride). Staining usually appeared within 1 h and was controlled under a microscope. Embryos were photographed with a Leica Wild M10 microscope under bright and dark field illumination. Neural tubes from 10.5 dpc embryos were cut along their dorsal midline and fiat mounted under a coverslip in 80% glycerol.
